SARAH STANDARD BENNETT: Open Payments
NPI 1861982993 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 32 payments from 16 companies in 2025. Trend: 2023 $536 · 2024 $627 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $109 |
| Grifols USA, LLC | 3 | $64 |
| GENZYME CORPORATION | 2 | $60 |
| Verona Pharma, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Insmed, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Viatris Specialty LLC | 2 | $37 |
Products named: NUCALA, DUPIXENT, TEZSPIRE, Ohtuvayre, Arikayce, Prolastin-C Liquid, WINREVAIR, OPSUMIT.
Industry payments across GA — which companies pay providers there.
